Antibacterial Pharmacology of Oxazolidinone Derivatives

Oxazolidinones are a unique class of synthetic antibiotics characterised by a 2-oxazolidinone core that interferes with bacterial protein synthesis. By binding to the peptidyl transferase centre of the 50S ribosomal subunit, they prevent formation of the functional initiation complex and thus halt bacterial growth. This mechanism confers potent activity against a broad spectrum of Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci and multidrug-resistant Mycobacterium tuberculosis. Most oxazolidinones exhibit excellent oral bioavailability, favourable tissue penetration and predictable pharmacokinetics, making them attractive for both hospital and community settings. However, prolonged exposure can give rise to adverse effects such as myelosuppression, peripheral and optic neuropathy and mitochondrial toxicity, which has driven the design of second-generation derivatives with modified aryl and heterocyclic substituents to improve selectivity and safety. Recent efforts have focused on optimising side-chain diversity, enhancing anti-biofilm properties and reducing interactions with human mitochondrial ribosomes. In parallel, structure–activity relationship studies have advanced compounds with lower resistance potential and improved therapeutic windows, addressing both acute and chronic Gram-positive infections globally.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Antibacterial Pharmacology of Oxazolidinone Derivatives publication trend

The graph below shows the total number of articles in antibacterial pharmacology of oxazolidinone derivatives across all publications each year (not limited to Nature Index journals).

Technical terms

Oxazolidinone: A class of synthetic antibiotics with a 2-oxazolidinone ring that inhibits bacterial protein synthesis at the 50S ribosomal subunit.

Minimum inhibitory concentration (MIC): The lowest drug concentration that prevents visible growth of a bacterial strain in vitro.

Biofilm: A structured community of bacterial cells enclosed in a self-produced polymeric matrix that adheres to surfaces and resists antimicrobial agents.

Mitochondrial toxicity: Unintended inhibition of mitochondrial protein synthesis leading to cellular dysfunction, often underlying adverse effects of prolonged antibiotic use.

Selectivity index (SI): Ratio of drug concentration causing mitochondrial inhibition to that required for antibacterial activity, indicating therapeutic safety margin.

References

1. New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?. Pharmaceutics (2024).
2. Optimization and Antibacterial Evaluation of Novel 3-(5-Fluoropyridine-3-yl)-2-oxazolidinone Derivatives Containing a Pyrimidine Substituted Piperazine. Molecules (2023).
3. Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections. Antimicrobial Agents and Chemotherapy (2023).